Logo image of HNST

HONEST CO INC/THE (HNST) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HNST - US4383331067 - Common Stock

2.81 USD
-0.05 (-1.75%)
Last: 12/15/2025, 8:00:02 PM
2.8 USD
-0.01 (-0.36%)
Pre-Market: 12/16/2025, 4:23:05 AM
Fundamental Rating

5

HNST gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. While HNST has a great health rating, there are worries on its profitability. While showing a medium growth rate, HNST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HNST had positive earnings in the past year.
In the past year HNST has reported a negative cash flow from operations.
In the past 5 years HNST always reported negative net income.
In multiple years HNST reported negative operating cash flow during the last 5 years.
HNST Yearly Net Income VS EBIT VS OCF VS FCFHNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.93%, HNST is in line with its industry, outperforming 58.33% of the companies in the same industry.
HNST has a Return On Equity of 3.72%. This is in the better half of the industry: HNST outperforms 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.88%, HNST is in line with its industry, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
ROA 2.93%
ROE 3.72%
ROIC 1.88%
ROA(3y)-14.1%
ROA(5y)-11.89%
ROE(3y)-22.95%
ROE(5y)-19.23%
ROIC(3y)N/A
ROIC(5y)N/A
HNST Yearly ROA, ROE, ROICHNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 1.85%, HNST is in line with its industry, outperforming 55.56% of the companies in the same industry.
Looking at the Operating Margin, with a value of 1.22%, HNST is in line with its industry, outperforming 47.22% of the companies in the same industry.
HNST's Gross Margin of 38.81% is on the low side compared to the rest of the industry. HNST is outperformed by 77.78% of its industry peers.
In the last couple of years the Gross Margin of HNST has grown nicely.
Industry RankSector Rank
OM 1.22%
PM (TTM) 1.85%
GM 38.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.71%
GM growth 5Y3.49%
HNST Yearly Profit, Operating, Gross MarginsHNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

8

2. Health

2.1 Basic Checks

HNST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HNST has more shares outstanding than it did 1 year ago.
HNST has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HNST Yearly Shares OutstandingHNST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HNST Yearly Total Debt VS Total AssetsHNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.40 indicates that HNST is not in any danger for bankruptcy at the moment.
HNST has a Altman-Z score of 3.40. This is in the better half of the industry: HNST outperforms 66.67% of its industry peers.
There is no outstanding debt for HNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACC0.21
WACC8.83%
HNST Yearly LT Debt VS Equity VS FCFHNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 4.82 indicates that HNST has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.82, HNST belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
HNST has a Quick Ratio of 2.73. This indicates that HNST is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HNST (2.73) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 4.82
Quick Ratio 2.73
HNST Yearly Current Assets VS Current LiabilitesHNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 250.00% over the past year.
HNST shows a small growth in Revenue. In the last year, the Revenue has grown by 3.89%.
The Revenue has been growing by 9.94% on average over the past years. This is quite good.
EPS 1Y (TTM)250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%318.75%
Revenue 1Y (TTM)3.89%
Revenue growth 3Y5.9%
Revenue growth 5Y9.94%
Sales Q2Q%-6.72%

3.2 Future

Based on estimates for the next years, HNST will show a very strong growth in Earnings Per Share. The EPS will grow by 66.09% on average per year.
HNST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.89% yearly.
EPS Next Y20.1%
EPS Next 2Y58.43%
EPS Next 3Y32.76%
EPS Next 5Y66.09%
Revenue Next Year-1.07%
Revenue Next 2Y-4.53%
Revenue Next 3Y-0.42%
Revenue Next 5Y5.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HNST Yearly Revenue VS EstimatesHNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
HNST Yearly EPS VS EstimatesHNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

2

4. Valuation

4.1 Price/Earnings Ratio

HNST is valuated quite expensively with a Price/Earnings ratio of 46.83.
Compared to the rest of the industry, the Price/Earnings ratio of HNST is on the same level as its industry peers.
HNST is valuated expensively when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 91.83, HNST can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as HNST.
When comparing the Price/Forward Earnings ratio of HNST to the average of the S&P500 Index (23.78), we can say HNST is valued expensively.
Industry RankSector Rank
PE 46.83
Fwd PE 91.83
HNST Price Earnings VS Forward Price EarningsHNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

HNST's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.06
HNST Per share dataHNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HNST does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as HNST's earnings are expected to grow with 32.76% in the coming years.
PEG (NY)2.33
PEG (5Y)N/A
EPS Next 2Y58.43%
EPS Next 3Y32.76%

0

5. Dividend

5.1 Amount

No dividends for HNST!.
Industry RankSector Rank
Dividend Yield 0%

HONEST CO INC/THE

NASDAQ:HNST (12/15/2025, 8:00:02 PM)

Premarket: 2.8 -0.01 (-0.36%)

2.81

-0.05 (-1.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners47.86%
Inst Owner Change-16.82%
Ins Owners13.15%
Ins Owner Change-0.43%
Market Cap314.13M
Revenue(TTM)383.12M
Net Income(TTM)7.07M
Analysts76.92
Price Target3.91 (39.15%)
Short Float %16.67%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)400.77%
Min EPS beat(2)166.24%
Max EPS beat(2)635.29%
EPS beat(4)4
Avg EPS beat(4)624.34%
Min EPS beat(4)34.64%
Max EPS beat(4)1661.18%
EPS beat(8)8
Avg EPS beat(8)350.72%
EPS beat(12)9
Avg EPS beat(12)214.83%
EPS beat(16)9
Avg EPS beat(16)151.54%
Revenue beat(2)0
Avg Revenue beat(2)-4.66%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-0.63%
Revenue beat(4)2
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)3.11%
Revenue beat(8)6
Avg Revenue beat(8)1.42%
Revenue beat(12)9
Avg Revenue beat(12)2.81%
Revenue beat(16)10
Avg Revenue beat(16)1.58%
PT rev (1m)-43.56%
PT rev (3m)-43.56%
EPS NQ rev (1m)-59.66%
EPS NQ rev (3m)-292.2%
EPS NY rev (1m)-147.96%
EPS NY rev (3m)-148.62%
Revenue NQ rev (1m)-3.81%
Revenue NQ rev (3m)-16.73%
Revenue NY rev (1m)-6.23%
Revenue NY rev (3m)-6.23%
Valuation
Industry RankSector Rank
PE 46.83
Fwd PE 91.83
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB 1.67
EV/EBITDA 32.06
EPS(TTM)0.06
EY2.14%
EPS(NY)0.03
Fwd EY1.09%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS3.43
BVpS1.7
TBVpS1.68
PEG (NY)2.33
PEG (5Y)N/A
Graham Number1.52
Profitability
Industry RankSector Rank
ROA 2.93%
ROE 3.72%
ROCE 2.38%
ROIC 1.88%
ROICexc 2.95%
ROICexgc 3.01%
OM 1.22%
PM (TTM) 1.85%
GM 38.81%
FCFM N/A
ROA(3y)-14.1%
ROA(5y)-11.89%
ROE(3y)-22.95%
ROE(5y)-19.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.71%
GM growth 5Y3.49%
F-Score5
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 21.07%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.82
Quick Ratio 2.73
Altman-Z 3.4
F-Score5
WACC8.83%
ROIC/WACC0.21
Cap/Depr(3y)48.33%
Cap/Depr(5y)30.88%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%318.75%
EPS Next Y20.1%
EPS Next 2Y58.43%
EPS Next 3Y32.76%
EPS Next 5Y66.09%
Revenue 1Y (TTM)3.89%
Revenue growth 3Y5.9%
Revenue growth 5Y9.94%
Sales Q2Q%-6.72%
Revenue Next Year-1.07%
Revenue Next 2Y-4.53%
Revenue Next 3Y-0.42%
Revenue Next 5Y5.89%
EBIT growth 1Y214.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year425.22%
EBIT Next 3Y75.45%
EBIT Next 5Y90.1%
FCF growth 1Y-20.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.86%
OCF growth 3YN/A
OCF growth 5YN/A

HONEST CO INC/THE / HNST FAQ

Can you provide the ChartMill fundamental rating for HONEST CO INC/THE?

ChartMill assigns a fundamental rating of 5 / 10 to HNST.


What is the valuation status for HNST stock?

ChartMill assigns a valuation rating of 2 / 10 to HONEST CO INC/THE (HNST). This can be considered as Overvalued.


What is the profitability of HNST stock?

HONEST CO INC/THE (HNST) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for HNST stock?

The Price/Earnings (PE) ratio for HONEST CO INC/THE (HNST) is 46.83 and the Price/Book (PB) ratio is 1.65.


Can you provide the financial health for HNST stock?

The financial health rating of HONEST CO INC/THE (HNST) is 8 / 10.